Prevention of glucocorticoid-induced osteoporosis with alendronate or alfacalcidol: Relation between change in bone mineral density, bone markers and calcium homeostasis.

被引：0
作者：
Jacobs, JWG
de Nijs, RNJ
Lems, WF
Geusens, PP
Huisman, MAM
Laan, RFJ
Bijlsma, JWJ
机构：
[1] Univ Utrecht, Med Ctr, Utrecht, Netherlands
[2] Free Univ Amsterdam Hosp, Amsterdam, Netherlands
[3] State Univ Limburg Hosp, NL-6201 BX Maastricht, Netherlands
[4] Sint Franciscus Hosp, Rotterdam, Netherlands
[5] Univ Med Ctr, Nijmegen, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [41] Bone quality in zebrafish vertebrae improves after alendronate administration in a glucocorticoid-induced osteoporosis model
    Bohns, Fabio Rocha
    Akhtar, Riaz
    Chuang, Yung-Jen
    Chen, Po-Yu
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2024, 154
  • [42] Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: A histomorphometric analysis of transiliac biopsies
    Chavassieux, PM
    Arlot, ME
    Roux, JP
    Portero, N
    Daifotis, A
    Yates, AJ
    Hamdy, NAT
    Malice, MP
    Freedholm, D
    Meunier, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 754 - 762
  • [43] Prevention and treatment of glucocorticoid-induced osteoporosis: A comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium
    Sambrook, PN
    Kotowicz, M
    Nash, P
    Styles, CB
    Naganathan, V
    Henderson-Briffa, KN
    Eisman, JA
    Nicholson, GC
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (05) : 919 - 924
  • [44] Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia
    H. Chandler
    D.J. Brooks
    G. Hattersley
    M.L. Bouxsein
    B. Lanske
    Osteoporosis International, 2019, 30 : 1607 - 1616
  • [45] Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia
    Chandler, H.
    Brooks, D. J.
    Hattersley, G.
    Bouxsein, M. L.
    Lanske, B.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (08) : 1607 - 1616
  • [46] Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis
    Lane, NE
    Sanchez, S
    Genant, HK
    Jenkins, DK
    Arnaud, CD
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 (05) : 434 - 442
  • [47] Short-Term Increases in Bone Turnover Markers Predict Parathyroid Hormone-Induced Spinal Bone Mineral Density Gains in Postmenopausal Women with Glucocorticoid-Induced Osteoporosis
    N. E. Lane
    S. Sanchez
    H. K. Genant
    D. K. Jenkins
    C. D. Arnaud
    Osteoporosis International, 2000, 11 : 434 - 442
  • [48] Glucocorticoid-induced osteoporosis induced poor bone quality, low bone mineral density, low muscle mass and high low back pain
    Koyama, Tomohisa
    Miyagi, Masayuki
    Inoue, Sho
    Tajima, Shuichiro
    Murata, Kosuke
    Kawakubo, Ayumu
    Uekusa, Yui
    Yokozeki, Yuji
    Fujimaki, Hisako
    Ishi, Daisuke
    Ishikawa, Koji
    Ohtori, Seiji
    Inage, Kazuhide
    Uchida, Kentaro
    Inoue, Gen
    Takaso, Masashi
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 173 - 173
  • [49] Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution
    Manning, Louise I.
    Briggs, Andrew M.
    Van Doornum, Sharon
    Kale, Ashwini
    Kantor, Susan
    Wark, John D.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [50] Romosozumab is associated with greater gain in bone mineral density at lumbar spine compared to denosumab in glucocorticoid-induced osteoporosis
    Shin, Sungjae
    Hong, Namki
    Han, Sookyoung
    Rhee, Yumie
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 275 - 275
12345